Childhood Asthma Management Program: Lessons learned

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 1, 2007, Pages 36-42

  Strunk, Robert C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asthma; childhood; clinical trial

Indexed keywords

ANTIINFLAMMATORY AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; METHACHOLINE; NEDOCROMIL; PREDNISOLONE; SALBUTAMOL;

ARTICLE; ASTHMA; BONE DENSITY; DISEASE DURATION; DISEASE SEVERITY; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENETICS; GROWTH; GROWTH RATE; HUMAN; INTERVENTION STUDY; LUNG FUNCTION; MEDICAL RESEARCH; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SEXUAL MATURATION; STANDARDIZATION; TREATMENT PLANNING;

EID: 33845955486     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.09.038     Document Type: Article

References (13)

1. Childhood Asthma Management Program Research Group. The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control Clin Trials 20 (1999) 91-120
2. Childhood Asthma Management Program Research Group. Design and implementation of a patient education center for the Childhood Asthma Management Program. Ann Allergy Asthma Immunol 81 (1998) 571-581
3. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343 (2000) 1054-1063
4. Tantisira K., Fuhlbrigge A., Tonascia J., Van Natta M., Zeiger R., Strunk R., et al. Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma. J Allergy Clin Immunol 117 (2006) 1264-1271
5. Covar R., Spahn J., Murphy J., and Szefler S. Progression of asthma measured by lung function in the Childhood Asthma Management Program. Am J Respir Crit Care Med 170 (2004) 234-241
6. Bacharier L., Raissy H., Wilson L., McWilliams B., Strunk R., and Kelly H. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics 113 (2004) 1693-1699
7. Covar R., Colvin R., Shapiro G., and Strunk R. Safety of methacholine challenges in a multicenter pediatric asthma study. J Allergy Clin Immunol 117 (2006) 709-711
8. Randolph A., Lange C., Silverman E., Lazarus R., Silverman E., Raby B., et al. The IL12B gene is associated with asthma. Am J Hum Genet 75 (2004) 709-715
9. Lyon H., Lange C., Lake S., Silverman E., Randolph A., Kwiatkowski D., et al. IL10 gene polymorphisms are associated with asthma phenotypes in children. Genet Epidemiol 26 (2004) 155-165
10. Raby B., Hwang E., Van Steen K., Tantisira K., Peng S., Litonjua A., et al. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am J Respir Crit Care Med 173 (2006) 64-70
11. Tantisira K., Lake S., Silverman E., Palmer L., Lazarus R., Silverman E., et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 13 (2004) 1353-1359
12. Tantisira K., Hwang E., Raby B., Silverman E., Lake S., Rochter B., et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci U S A 101 (2004) 18099-18104
13. Strunk R., Weiss S., Yates K., Tonascia J., Zeiger R., and Szefler S. Mild to moderate asthma affects lung growth in children and adolescents. J Allergy Clin Immunol 118 (2006) 1040-1047